Effects of a Patient Directed Web-portal to Improve Health Literacy Skills (PREP)
Access to the best available evidence, and the ability to obtain and understand such information is seen as necessary to protect the public's interests and critical to empowerment, but is also a precondition for participation in the decision making.
A web portal serving as a generic (non disease- specific) tailored tool was developed in the conceptual framework of shared decision making and evidence based practice to improve the lay- public's critical and social literacy skills and activation. A randomized controlled parallel trial using a simple randomization procedure will be conducted, including 200 parents of children <4 with internet access. Parents will be allocated to receive either the portal or no intervention. Primary and secondary outcomes include: the ability to find research based information, critical appraisal skills, perceived behavioural control, attitudes and perceived pressure associated with searching for information, and participation.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Oslo, Norvège, 0130
- Oslo University College, Faculty of Nursing
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Parents of children age <4 will be recruited with access to internet.
Exclusion Criteria:
- Participants will be excluded if one other in the household already participates in the study (due to spill-over effect) and if they do not have children <4.
- Since the recruitment will be done online, there is no need to screen for access to internet.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Portal arm
|
The portal was tailored to improve the lay public's' "healthy skepticism", or in other words, critical and social literacy skills to assist patients in the decision-making process and for improving access to health information and participation. Illustrated by typical examples which can be found in the news and through patient stories, the portal provides an introduction to research methods, the underlying principles of science and critical assessment tools appropriate for a lay public.
|
|
Aucune intervention: Treatment as usal
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Changes in predictors of search and use of health information
Délai: Week 3
|
Based on the theory of planned behavioral manual a questionnaire has been developed and validated in order to explore what predictors (efficacy, attitudes and perceived pressure) to search and use of health infomration.
|
Week 3
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
The ability to find reliable answers to a health question
Délai: Week 1
|
Participants will be asked to formulate a (health) question and to find information that can answer this question.
The participants will be asked to copy and paste the internet link to the information they found.The outcome will be evaluated pragmatically by categorizing the information as based on: 1. research or 2. expert advice/ other.
The information will be categorized blindly by two independent researchers.
The direction of effect is expected to be positive, in that more participants will find research based information than those in the control group.
|
Week 1
|
|
Critical appraisal of health information
Délai: Week 2
|
Participants will be asked to rate a piece of health information about childhood vaccination using DISCERNs item number 16. DISCERN is an instrument designed to judge the quality of written information about treatment choices.
The mean value rating of the information will be measured against a "standard" rating made by experts on the same information.
The direction of effect is predicted to be positive, in that the mean overall score of the intervention group will be closer to the standard than the control group.
|
Week 2
|
|
Participation (activation)
Délai: Week 3
|
The patient activation measure (PAM) has been developed to measure activation.
The instrument includes 4 domains; believing the patient role is important, having confidence and knowledge necessary to taking action, actually taking action to improve one's health, and staying the course under stress.
|
Week 3
|
|
Satisfaction with portal
Délai: Week 3
|
We will also ask participants to comment on satisfaction with the portal after the other data collection has been submitted.
This will be done based on the Honeycomb criteria which were also used in the qualitative evaluation.
The honeycomb model is a well-renowned and much used instrument to measure user experience
|
Week 3
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Sølvi Helseth, Professor, Oslo University College
- Directeur d'études: Arild Bjørndal, Professor, Oslo University
- Chercheur principal: Astrid Austvoll-Dahlgren, MA, Oslo University College
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- REK S-07414b [1.2007.2076]
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .